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Background: Impetigo is a mild bacterial skin infection of childhood that is usually managed empir-
ically in primary care.
Objective: To establish the prevalence and associations of impetigo in general practice (GP) registrars’ 
consultations.
Methods: Cross-sectional analysis of the Registrar Clinical Encounters in Training (ReCEnT) study 
data.
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of 44.5% (interquartile range [IQR] 34%-49.2%), there is 
a lack of data for non-Aboriginal and Torres Strait Islander 
Australian populations [2].
The prevalence of impetigo presenting in the general 
population in Australia is unknown, and its associations are 
unexplored. The aim of this study is to investigate the preva-
lence of impetigo presenting to Australian GP registrars, and 
the associations and outcomes of these consultations.
Methods
ReCEnT Project
Data were analyzed from the multisite cohort study of Aus-
tralian GP registrars’ clinical practice, detailed methodology 
of which is described elsewhere [10].
Outcome Factor
The outcome factor was a problem/diagnosis being “impe-
tigo,” defined by the International Classification of Primary 
Care, second edition classification system [11] as code S84.
Independent variables were related to registrar, patient, 
practice, and consultation.
Registrar Variables
Registrar variables were age, sex, training term, place of medi-
cal qualification (Australia/international), full-time/part-time, 
and worked at the practice previously.
Patient Variables
Patient variables were age, sex, Aboriginal/Torres Strait 
Islander, non–English-speaking background (NESB), prob-
lem/diagnosis was new, new to the practice, and new to the 
registrar.
Practice Variables
Practice variables were training “region,” rurality/urbanity, 
practice size (number of GPs), socioeconomic status of area, 
and routine bulk-billing. Postal codes defined rurality of loca-
tion using Australian Standard Geographical Classification-Re-
moteness Area classification [12] and the location’s Socioeco-
nomic Index for Area Relative Index of Disadvantage [13].
What is known about the topic?
Impetigo is a bacterial skin infection, most prevalent in 
remote Aboriginal communities, with implications for anti-
microbial stewardship.
What does this paper add?
Prevalence of impetigo and associated characteristics in the 
Australian population, outside of remote Aboriginal com-
munities.
Introduction
Impetigo is a common skin infection [1,2] caused by Staph-
ylococcus aureus or Streptococcus pyogenes [2,3]. It is often 
seen in childhood and is associated with poverty and tropical 
environments [2] and is most prevalent in remote indigenous 
Australian children [2]. As a mild disease with good progno-
sis and potential for self-resolution [3], impetigo is managed 
in primary care [3,4], but because of its significant disease 
burden and highly contagious nature [2,3], empirical anti-
biotic treatment is recommended. Skin swabs for bacterial 
culture are reserved for severe/recurrent disease or empirical 
treatment failure [5,6]. Thus the management of impetigo 
has considerable implications for antibiotic stewardship. 
Previous analysis from the Registrar Clinical Encounters in 
Training (ReCEnT) study [7] raised questions regarding inter-
pretation of Australian guidelines for impetigo management 
and the subsequent implications for antibiotic stewardship. 
Characterizing the prevalence of impetigo and its associations 
is important to optimize and explore management that pro-
motes antimicrobial stewardship.
Skin conditions are among the most common problems 
in Australian general practice (GP), managed in 17.4 per 100 
encounters, and they account for 11.3% of problems [8]. 
Despite this frequency, studies have shown that registrars find 
skin conditions challenging and are not adequately prepared 
for the dermatology burden in the community [9]. Impe-
tigo prevalence in global communities has been measured 
extensively, and while it is highest in remote Aboriginal and 
Torres Strait Islander populations, with a median prevalence 
Results: Impetigo was managed in 0.24% of problems and 0.43% of consultations. Patient variables 
associated with impetigo presentations were younger age and impetigo as a new problem, while pa-
tients with non–English-speaking backgrounds were less likely to present with impetigo. Associated 
registrar variables were being new to the registrar and practicing in outer regional/remote locations. 
Compared with all other problems/diagnoses, impetigo more often involved information seeking, or-
dering pathology, and prescription of medication, but less often involved follow-up or referral.
Conclusions: Impetigo accounts for 0.43 per 100 GP registrar consultations in Australia. Association 
with outer regional/remote areas may reflect climate and socioeconomic factors that predispose to 
impetigo. Associated pathology requests may reflect a lack of confidence in GP registrars’ management 
of impetigo. Cultural differences may exist regarding health-seeking behavior relating to impetigo.
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Results
A total of 1,741 registrars (response rate 96%) contrib-
uted 377,980 patient problems over 214,888 consultations. 
Impetigo was diagnosed in 915 consultations, accounting 
for 0.24% of all problems and managed in 0.43 per 100 
consultations.
Characteristics Associated With an Impetigo 
Diagnosis
On multivariable analysis, younger patients (age 0-14, com-
pared to 15-34: odds ratio [OR] 7.14, 95% CI 5.75-8.86, P 
< 0.001) and patients new to the registrar (OR 1.33, 95% CI 
1.11-1.60, P = 0.002) were more likely to present with impe-
tigo (Table 1). NESB patients were less likely to present with 
impetigo (OR 0.57, 95% CI 0.36-0.89, P = 0.015). Registrars 
working in outer regional/remote/very remote areas (OR 
1.66, compared to major cities: 95% CI 1.11-2.48, P = 0.014) 
and male registrars (OR 1.20, 95% CI 1.45-1.01, P = 0.038) 
were more likely to see patients with impetigo.
What Happens Differently During Impetigo 
Consultations?
Impetigo consultations were significantly shorter in duration 
(14 vs 19 minutes on unadjusted analysis and OR 0.94 per 
additional minute, 95% CI 0.93-0.96, P < 0.001 on multi-
variable analysis) and the registrars were more likely to seek 
help (OR 2.53, 95% CI 2.13-3.02, P < 0.001) (Table 1). Of 
those who sought help from supervisors, the highest propor-
tion were first-term registrars (70.7%) (Table 2). The most 
frequent resource type used was electronic; the most com-
mon was Therapeutic Guidelines (61.65%) (Tables 2 and 3). 
Impetigo was more likely to present as a new, rather than 
existing, problem (OR 2.19, 95% CI 1.74-2.76, P < 0.001).
What Outcomes Are Different in Impetigo 
Consultations?
Impetigo consultations were significantly more likely to 
involve pathology being ordered (OR 2.43, 95% CI 1.93-
3.06, P < 0.001) (Table 1), the majority being skin swabs for 
bacterial culture (47%) (Table 4). Impetigo consultations 
were more likely to involve medication prescription (OR 
12.8, 95% CI 9.34-17.5, P < 0.001) but less likely to result in 
follow-up (OR 0.71, 95% CI 0.59-0.86, P = 0.001) or referral 
(OR 0.11, 95% CI 0.04-0.29, P < 0.0001). Of impetigo con-
sultations, 83% did not result in generation of a learning goal.
Discussion
Prevalence
Impetigo accounted for 0.24% of problems seen by Austra-
lian GP registrars and was managed in 0.43 per 100 consul-
Consultation and Educational Variables
Consultation variables included duration, number of diagno-
ses/problems, pathology/imaging ordered, specialist referral 
made, follow-up organized, and medication prescribed. Edu-
cational variables included seeking information or assistance 
and generating learning goals.
Statistical Analysis
We conducted cross-sectional analysis of data from the 
ReCEnT cohort study performed on 16 rounds of 6-monthly 
collected data from 2010-2017, with analysis at the individ-
ual problem/diagnosis level.
The proportion of registrars’ impetigo problems/diag-
noses and the proportion of impetigo consultations were 
calculated, with 95% confidence intervals (CIs).
Impetigo vs Other Problems/Diagnoses
To test associations of a problem/diagnosis being impetigo, 
simple and multiple logistic regression analyses were used 
within the generalized estimating equations framework, 
accounting for clustering of patients within registrars. All 
variables with a P value <0.20 in univariate analysis were 
included in the multiple regression model. Covariates with 
P > 0.2 in the multivariable model were tested for removal. 
Covariates were removed if this did not substantively change 
the remaining coefficients in the model.
To examine 3 separate issues within our research ques-
tion, 3 models were built, each with the dependent variable 
“impetigo problem/diagnosis”:
1. To examine associations of a problem/diagnosis being 
impetigo (compared with other problems/diagnoses), 
patient, practice and registrar independent variables were 
entered in a regression model.
2. To examine in-consultation differences of an impetigo 
problem/diagnosis compared with other problems/diagno-
ses, the above variables were entered in a model along with 
consultation duration, information/assistance accessed by 
registrar, and number of problems/diagnoses dealt with in 
consultation.
3. To examine whether actions from managing impetigo 
differ from those managing other problems/diagnoses, all 
variables entered in the previous 2 models were entered 
in a model along with learning goals generated, follow-up 
organized, specialist referrals made, and pathology and 
imaging ordered.
Statistical analyses were programmed using STATA 14.0 
and SAS v9.4. P values <0.05 were considered statistically 
significant.
Ethics Approval
The University of Newcastle Human Research Ethics Com-
mittee approved the study (Reference H-2009-0323).
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Table 2. Resource Type Used for Impetigo Consultations Presented by Training Term
Resource Type Used in Impetigo 
Consultation
Term 1 Frequency 
(%)
Term 2 Frequency 
(%)
Term 3 Frequency 
(%)
Total
Electronic 113 (52.6) 54 (25.1) 48 (22.3) 215
Supervisor 65 (70.7) 21 (22.8) 6 (6.5) 92
Book 13 (72.2) 3 (16.7) 2 (11.1) 18
Specialist 0 (0) 2 (66.7) 1 (3.3) 3
Other 5 (55.6) 2 (22.2) 2 (22.2) 9
Table 1. Patient, Registrar, and Consultation Characteristics Associated With Impetigo
Variable Class
Univariate Adjusted
OR (95% CI) P OR (95% CI) P
Patient variables
 Patient age group 0-14 years 7.97 (6.64, 9.57) <0.0001 7.14 (5.75, 8.86) <0.0001
35-64 years 0.38 (0.29, 0.50) <0.0001 0.38 (0.28, 0.52) <0.0001
65+ years 0.12 (0.07, 0.20) <0.0001 0.12 (0.07, 0.24) <0.0001
 Patient sex Female 0.66 (0.57, 0.76) <0.0001 0.87 (0.74, 1.02) 0.0795
  Aboriginal or Torres Strait 
Islander
Yes 2.66 (1.78, 3.98) <0.0001 1.48 (0.96, 2.28) 0.0758
  Non–English-speaking 
background 
Yes 0.40 (0.27, 0.58) <0.0001 0.57 (0.36, 0.89) 0.0145
 Patient/practice status New to practice 1.90 (1.44, 2.50) <0.0001 0.93 (0.67, 1.29) 0.6588
New to registrar 2.11 (1.80, 2.48) <0.0001 1.33 (1.11, 1.60) 0.0018
Registrar variables
 Registrar sex Female 0.75 (0.64, 0.87) 0.0003 0.83 (0.69, 0.99) 0.0382
  Worked at practice previously Yes 0.85 (0.70, 1.03) 0.0992 0.82 (0.66, 1.02) 0.0758
 Registrar age 1.01 (1.00, 1.02) 0.1100 1.00 (0.98, 1.01) 0.7376
Practice variables
 Practice routinely bulk bills Yes 0.66 (0.53, 0.81) <0.0001 0.78 (0.60, 1.01) 0.0622
 Rurality Inner regional 1.32 (1.10, 1.58) 0.0024 1.14 (0.91, 1.43) 0.2516
Outer regional remote 1.41 (1.13, 1.77) 0.0029 1.66 (1.11, 2.48) 0.0139
 Socioeconomic Index for Area 1.03 (1.00, 1.05) 0.0587 1.02 (0.98, 1.06) 0.2831
 Region Region 2 0.40 (0.28, 0.57) <0.0001 0.37 (0.24, 0.56) <0.0001
Region 3 0.84 (0.66, 1.07) 0.1525 0.66 (0.48, 0.90) 0.0080
Region 4 0.65 (0.54, 0.77) <0.0001 0.54 (0.42, 0.68) <0.0001
Region 5 1.47 (1.00, 2.16) 0.0475 0.79 (0.45, 1.39) 0.4087
Region 6 0.49 (0.34, 0.72) 0.0002 0.47 (0.29, 0.78) 0.0032
Consultation variables
 New problem seen Yes 4.14 (3.36, 5.11) <0.0001 2.19 (1.74, 2.76) <0.0001
 Sought help any source Yes 2.68 (2.32, 3.11) <0.0001 2.53 (2.13, 3.02) <0.0001
 Consultation duration 0.93 (0.92, 0.94) <0.0001 0.94 (0.93, 0.96) <0.0001
 No. of problems 0.44 (0.40, 0.49) <0.0001 0.95 (0.84, 1.07) 0.4079
Consultation outcome variables
 Pathology ordered Yes 1.13 (0.95, 1.35) 0.1705 2.43 (1.93, 3.06) <0.0001
 Follow-up ordered Yes 0.83 (0.72, 0.96) 0.0137 0.71 (0.59, 0.86) 0.0004
 Referral ordered Yes 0.03 (0.01, 0.08) <0.0001 0.11 (0.04, 0.29) <0.0001
 Medication prescribed Yes 15.7 (12.1, 20.3) <0.0001 12.8 (9.34, 17.5) <0.0001
CI = confidence interval; OR = odds ratio.
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impetigo consultations in our study compared with main-
stream GPs.
Patients being more likely to present to the registrar 
with impetigo as a new problem or for the first time reflects 
impetigo’s acute nature. Patients may be more willing to 
see registrars for acute issues or perceived minor problems 
[22]. Consultations for acute conditions are also booked on 
shorter notice, with the first doctor available, who is usually 
the registrar [9].
NESB patients were less likely to present with impetigo. 
One-tenth of GP patients are from NESB [8] and 21% of 
Australians speak a language other than English at home [23]. 
Our finding may reflect cultural practices that predispose 
patients to impetigo; also as impetigo is a mild condition 
with the potential for self-resolution, this may reflect differ-
ent cultural approaches to health-seeking behavior regarding 
impetigo.
Differences in Impetigo Consultations
Impetigo consultations were shorter; this is expected as impe-
tigo is a common condition with a clinical diagnosis, system-
ically well patients [3,4], and clear guidelines available [6].
Registrars are more likely to seek information/assistance 
for impetigo despite its being a mild disease. First-term regis-
trars were more likely to seek help from their supervisor than 
those in advanced terms, which may reflect initial inadequate 
preparation for the dermatological disease burden in the 
community [9], with confidence improving with experience. 
The most commonly used resources were electronic (Table 2); 
the Therapeutic Guidelines [6] were most often used (Table 
3). In impetigo consultations the majority of registrars (83%) 
did not generate learning goals, patients were mostly children, 
and medication was usually prescribed; therefore, registrars 
may have used this reference for dose checking rather than 
guidance on diagnosis/management.
tations. Finding comparable data regarding the prevalence 
of impetigo is difficult. The BEACH study grouped impetigo 
with other “skin problems,” which were seen in 17.4 per 100 
consultations [8]. In Aboriginal and Torres Strait Islander 
communities, impetigo encounters have been recorded as high 
as 7.5 per 100 consultations [14]. In a Dutch study, yearly 
impetigo incidence was 4 per 100 patients aged <18 years; 
however, the proportion of consultations was not measured 
[15]. Impetigo prevalence in global communities has been 
measured more extensively, although the majority of data was 
collected before 2010, with only 3 studies from 2010-2015 
(3%) [2]. Impetigo prevalence is highest in remote Aboriginal 
and Torres Strait Islander populations with a median preva-
lence of 44.5% (IQR 34%-49.2%) [2]. A Canadian study of 2 
First Nation communities found impetigo prevalence between 
1% and 4.2% [16]; in comparison, the median prevalence of 
impetigo in Africa is 7% (IQR 4.1%-12.3%) [2] and 0.75% 
in Japan [17]. There is a paucity of prevalence data for North 
America, China, most European countries and non-Aborigi-
nal Australian populations [2,18].
Impetigo Diagnosis Characteristics
Registrars working in outer regional/remote areas were more 
likely to see patients with impetigo. Impetigo is most preva-
lent in poorly resourced areas and tropical/arid climates [2]; 
the regional differences seen in our study may reflect lower 
income level and more tropical/arid climates [12,19] in Aus-
tralian outer regional/remote areas.
Most patients with impetigo were <14 years, consistent 
with impetigo being a childhood disease [1,3]. Registrars see 
younger patients than do established GPs [8,20]; of registrar 
consultations, 17% involve patients <14 years [20,21] com-
pared with 12% for established GPs [8]. Registrars are also 
more likely to see new patients, new problems, and acute 
illnesses [8], which may result in an elevated proportion of 
Table 3. Electronic Resources Used for  
Impetigo Consultations
Resource Frequency (%)
Therapeutic Guidelines 127 (61.65)
Royal Children’s Hospital 
Guidelines
22 (10.68)
DermNet NZ 17 (8.25)
Australian Medicines Handbook 11 (5.34)
Monthly Index of Medical 
Specialties (MIMS online)
6 (2.91)
Murtagh's General Practice 4 (1.94)
Other 19 (9.2)
Total 206
Table 4. Pathology Ordered for Impetigo
Pathology request Frequency (%)
Skin swab MC&S 96 (47)
Swab MC&S 57 (28)
Nose swab MC&S 16 (7.9)
Herpes simplex culture 11 (5.4)




MC&S = microscopy, culture and sensitivity.
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Different Outcomes in Impetigo Consultations
Impetigo consultations were more likely to involve pathology 
being ordered, the majority being skin swabs for bacterial 
culture (Table 4), and medication prescription. As guide-
lines advise empirical treatment for impetigo, reserving skin 
swabs for severe, resistant, or recurrent disease [6], this may 
demonstrate lack of confidence with treating dermatological 
conditions. Follow-up and referrals were less likely in impe-
tigo consultations, reflecting the mild nature of the disease 
and preferred management in primary care [3,4].
Strengths and Limitations
The strengths of this study are a large sample size of GP regis-
trars with a high response rate from across Australia, includ-
ing major cities and remote areas. A limitation of the analysis 
and interpretation of the data is the absence of information 
regarding the severity of impetigo. We are unable to account 
for this variable in our interpretation, and low numbers of 
Aboriginal and Torres Strait Islander patients (4%) means we 
were underpowered to analyze this variable.
Conclusions
Impetigo accounts for 0.43 per 100 consultations seen by 
Australian GP registrars. It is more common in outer regional/
remote/very remote areas and usually presents as a new 
problem. NESB patients are less likely to present with impe-
tigo, which may reflect different cultural approaches to the 
management of a mild, potentially self-limiting condition. 
Impetigo was associated with pathology being ordered, which 
may reflect a lack of confidence in Australian GP registrars 
when dealing with this presentation.
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